Würzburg

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma3 trials

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Completed3 trials

Lead sponsor

• Janssen Research & Development, LLC3 trials

Closed trials

• Completed

  A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma

  NCT02316106· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

  NCT02195479· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

  NCT02136134· Phase 3· Janssen Research & Development, LLC· Source